{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T11:53:57Z","timestamp":1769514837888,"version":"3.49.0"},"reference-count":26,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Prostaglandins & Other Lipid Mediators"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1016\/j.prostaglandins.2021.106536","type":"journal-article","created":{"date-parts":[[2021,2,6]],"date-time":"2021-02-06T08:40:05Z","timestamp":1612600805000},"page":"106536","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"special_numbering":"C","title":["Circulating microRNA-126 &122 in patients with coronary artery disease: Correlation with small dense LDL"],"prefix":"10.1016","volume":"153","author":[{"given":"Sridhar","family":"Mishra","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aliya","family":"Rizvi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akshay","family":"Pradhan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marco A.","family":"Perrone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wahid","family":"Ali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.prostaglandins.2021.106536_bib0005","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1038\/nature10146","article-title":"Progress and challenges in translating the biology of atherosclerosis","volume":"473","author":"Libby","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.prostaglandins.2021.106536_bib0010","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/j.jacc.2011.03.052","article-title":"The year in atherothrombosis","volume":"58","author":"Sanz","year":"2011","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.prostaglandins.2021.106536_bib0015","doi-asserted-by":"crossref","first-page":"3481","DOI":"10.1161\/CIRCULATIONAHA.105.537878","article-title":"Pathophysiology of coronary artery disease","volume":"111","author":"Libby","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.prostaglandins.2021.106536_bib0020","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1161\/01.CIR.97.18.1837","article-title":"Prediction of coronary heart disease using risk factor categories","volume":"97","author":"Wilson","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.prostaglandins.2021.106536_bib0025","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1161\/CIRCULATIONAHA.106.676890","article-title":"Sub endothelial lipoprotein retention as the initiating process in atherosclerosis: update and therapeutic implications","volume":"116","author":"Tabas","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.prostaglandins.2021.106536_bib0030","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1001\/jama.298.3.299","article-title":"Nonfasting triglycerides and risk of myocardial infarction, ischemic heart disease, and death in men and women","volume":"298","author":"Nordestgaard","year":"2007","journal-title":"JAMA"},{"key":"10.1016\/j.prostaglandins.2021.106536_bib0035","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1161\/01.CIR.82.2.495","article-title":"Atherogenic lipoprotein phenotype, A proposed genetic marker for coronary heart disease risk","volume":"82","author":"Austin","year":"1990","journal-title":"Circulation"},{"key":"10.1016\/j.prostaglandins.2021.106536_bib0040","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1161\/01.ATV.11.2.298","article-title":"Enhanced susceptibility to in vitro oxidation of the dense low density lipoprotein subfraction in healthy subjects","volume":"11","author":"de Graaf","year":"1991","journal-title":"Arterioscler. Thromb."},{"key":"10.1016\/j.prostaglandins.2021.106536_bib0045","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1161\/01.ATV.19.3.810","article-title":"Cholesteryl ester hydroperoxide lability is a key feature of the oxidative susceptibility of small, dense LDL","volume":"19","author":"Chancharme","year":"1999","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.prostaglandins.2021.106536_bib0050","doi-asserted-by":"crossref","unstructured":"S. Ip, A.H. Lichtenstein, M. Chung, J. Lau, E.M. Balk, Systematic review: association of low-density lipoprotein subfractions with cardiovascular outcomes, Ann. Intern. Med. 150; 1: 474\u2013484.","DOI":"10.7326\/0003-4819-150-7-200904070-00007"},{"key":"10.1016\/j.prostaglandins.2021.106536_bib0055","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1093\/cvr\/cvn137","article-title":"MicroRNAs: novel regulators in cardiac development and disease","volume":"79","author":"Thum","year":"2008","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.prostaglandins.2021.106536_bib0060","first-page":"983","article-title":"Biological significance of miR-126 expression in atrial fibrillation and heart failure, Brazilian","volume":"48","author":"Wei","year":"2015","journal-title":"J. Med. Biol. Res."},{"key":"10.1016\/j.prostaglandins.2021.106536_bib0065","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/1477-9560-10-16","article-title":"Circulating microRNA-126 in patients with coronary artery disease: correlation with LDL cholesterol","volume":"10","author":"Sun","year":"2012","journal-title":"Thromb. J."},{"key":"10.1016\/j.prostaglandins.2021.106536_bib0070","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1161\/CIRCULATIONAHA.107.188208","volume":"117","author":"King","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.prostaglandins.2021.106536_bib0075","doi-asserted-by":"crossref","first-page":"474","DOI":"10.4314\/ahs.v17i2.22","article-title":"Expression of miR-126 and its potential function in coronary artery disease","volume":"17","author":"Wang","year":"2017","journal-title":"Afr. Health Sci."},{"key":"10.1016\/j.prostaglandins.2021.106536_bib0080","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1253\/circj.CJ-10-0457","article-title":"Assessment of plasma miRNAs in congestive heart failure","volume":"75","author":"Fukushima","year":"2011","journal-title":"Circ. J."},{"key":"10.1016\/j.prostaglandins.2021.106536_bib0085","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1159\/000447794","article-title":"Plasma microRNA-126-5p is associated with the complexity and severity of coronary artery disease in patients with stable angina pectoris","volume":"39","author":"Li","year":"2016","journal-title":"Cell. Physiol. Biochem."},{"key":"10.1016\/j.prostaglandins.2021.106536_bib0090","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1161\/CIRCGENETICS.108.782730","article-title":"Correlation of peripheral-blood gene expression with the extent of coronary artery stenosis","volume":"1","author":"Wingrove","year":"2008","journal-title":"Circ. Cardiovasc. Genet."},{"key":"10.1016\/j.prostaglandins.2021.106536_bib0095","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1161\/CIRCRESAHA.111.247452","article-title":"Circulating microRNAs: novel biomarkers and extracellular communicators in cardiovascular disease?","volume":"110","author":"Creemers","year":"2012","journal-title":"Circ. Res."},{"key":"10.1016\/j.prostaglandins.2021.106536_bib0100","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1161\/CIRCRESAHA.109.215566","article-title":"Circulating microRNAs in patients with coronary artery disease","volume":"107","author":"Fichtlscherer","year":"2010","journal-title":"Circ. Res."},{"key":"10.1016\/j.prostaglandins.2021.106536_bib0105","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1476-511X-11-55","article-title":"Plasma levels of lipometabolism-related miR-122 and miR-370 are increased in patients with hyperlipidemia and associated with coronary artery disease","volume":"11","author":"Gao","year":"2012","journal-title":"Lipids Health Dis."},{"key":"10.1016\/j.prostaglandins.2021.106536_bib0110","doi-asserted-by":"crossref","first-page":"474","DOI":"10.4314\/ahs.v17i2.22","article-title":"Expression of miR-126 and its potential function in coronary artery disease","volume":"17","author":"Wang","year":"2017","journal-title":"Afr. Health Sci."},{"key":"10.1016\/j.prostaglandins.2021.106536_bib0115","doi-asserted-by":"crossref","first-page":"2383","DOI":"10.1161\/ATVBAHA.111.226696","article-title":"Circulating microRNAs: biomarkers or mediators of cardiovascular diseases?","volume":"31","author":"Fichtlscherer","year":"2011","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.prostaglandins.2021.106536_bib0120","doi-asserted-by":"crossref","first-page":"1936","DOI":"10.1161\/CIRCULATIONAHA.111.037572","article-title":"Transcoronary concentration gradients of circulating microRNAs","volume":"124","author":"De Rosa","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.prostaglandins.2021.106536_bib0125","article-title":"Plasma miR-126 is a potential biomarker for early prediction of type 2 diabetes mellitus in susceptible individuals","volume":"25","author":"Zhang","year":"2013","journal-title":"Biomed. Res. Int."},{"key":"10.1016\/j.prostaglandins.2021.106536_bib0130","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.bbrc.2010.12.119","article-title":"Dysregulation of angiogenesis-related microRNAs in endothelial progenitor cells from patients with coronary artery disease","volume":"405","author":"Zhang","year":"2011","journal-title":"Biochem. Biophys. Res. Commun."}],"container-title":["Prostaglandins & Other Lipid Mediators"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1098882321000113?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1098882321000113?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T02:02:29Z","timestamp":1761098549000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1098882321000113"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4]]},"references-count":26,"alternative-id":["S1098882321000113"],"URL":"https:\/\/doi.org\/10.1016\/j.prostaglandins.2021.106536","relation":{},"ISSN":["1098-8823"],"issn-type":[{"value":"1098-8823","type":"print"}],"subject":[],"published":{"date-parts":[[2021,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Circulating microRNA-126 &122 in patients with coronary artery disease: Correlation with small dense LDL","name":"articletitle","label":"Article Title"},{"value":"Prostaglandins & Other Lipid Mediators","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.prostaglandins.2021.106536","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"106536"}}